Delays in Initiating Post-operative Prophylactic Biologic Therapy Are Common Among Crohn ’s Disease Patients

ConclusionsThere are a substantial number of delays in initiating post-operative prophylactic biologic therapy in high-risk patients. Identifying susceptible patients by insurance type or absence of pre-operative therapy can focus future improvement efforts. Additionally, consultation with IBD-specialized providers should be considered in peri-surgical IBD care.
Source: Digestive Diseases and Sciences - Category: Gastroenterology Source Type: research